HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 58 filers reported holding HOOKIPA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $394,831 | -0.6% | 640,960 | +42.0% | 0.00% | – |
Q2 2023 | $397,174 | +119.9% | 451,334 | +83.9% | 0.00% | – |
Q1 2023 | $180,621 | +586.7% | 245,409 | +655.8% | 0.00% | – |
Q4 2022 | $26,301 | -17.8% | 32,470 | +34.3% | 0.00% | – |
Q3 2022 | $32,000 | -77.3% | 24,179 | -72.1% | 0.00% | – |
Q2 2022 | $141,000 | +31.8% | 86,600 | +84.7% | 0.00% | – |
Q1 2022 | $107,000 | -60.5% | 46,889 | -59.7% | 0.00% | – |
Q4 2021 | $271,000 | +36.9% | 116,483 | +245.4% | 0.00% | – |
Q3 2021 | $198,000 | -85.5% | 33,725 | -77.4% | 0.00% | – |
Q2 2021 | $1,367,000 | +2479.2% | 149,256 | +3639.8% | 0.00% | – |
Q1 2021 | $53,000 | -80.3% | 3,991 | -83.6% | 0.00% | – |
Q4 2020 | $269,000 | +163.7% | 24,271 | +124.5% | 0.00% | – |
Q3 2020 | $102,000 | -39.6% | 10,811 | -25.5% | 0.00% | – |
Q2 2020 | $169,000 | +275.6% | 14,505 | +164.4% | 0.00% | – |
Q1 2020 | $45,000 | -72.6% | 5,485 | -59.0% | 0.00% | – |
Q4 2019 | $164,000 | +1722.2% | 13,375 | +957.3% | 0.00% | – |
Q3 2019 | $9,000 | -90.9% | 1,265 | -91.4% | 0.00% | – |
Q2 2019 | $99,000 | – | 14,791 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |